Journal for ImmunoTherapy of Cancer (JITC) Impact…

Journal for ImmunoTherapy of Cancer (JITC) Impact Factor

The Journal Impact Factor assigned by Clarivate's Journal Citation Reports to the Journal for ImmunoTherapy of Cancer (JITC): the citations received in a data year by JITC items published in the two preceding years, divided by the number of citable items from those years. JITC announced 11.7 for the 2025 data year.

ByCASRAI Editorial Board

· Last updated 8 Nov 2026

JITC’s current Impact Factor and the year it applies to

JITC reported that its 2025 Impact Factor increased to 11.7. That wording comes from the journal’s own announcement, republished by OncoDaily on 19 June 2026, which describes the impact factor as one of several indicators of the journal’s performance and engagement. The post also states that the figure places JITC among the top 5% of immunology journals and the top 9% of oncology journals in the 2025 Journal Citation Reports.

Clarivate issues a new JCR release each June, so the number is tied to a data year and is replaced the following year. The 2025 data year is the one released in June 2026.

How the JITC Impact Factor is calculated

The Journal Impact Factor is a ratio. The numerator is the citations received in the data year by items the journal published in the two preceding years; the denominator is the number of citable items it published in those two years. SITC’s description of JITC’s first impact factor shows the window concretely: the 2017 value was based on 2017 citations to manuscripts published in 2015 and 2016. By the same rule, the 2025 value counts citations made in 2025 to JITC items published in 2023 and 2024.

JITC’s impact factor history

JCR data year	Journal Impact Factor	Source
2017	8.374 (first impact factor)	SITC announcement, 26 June 2018
2025	11.7	JITC post republished by OncoDaily, 19 June 2026

These are the two values CASRAI has read at source. Intermediate years are not listed because they have not been checked against a primary source. When it announced the first value, SITC said it placed JITC in the top 8 percent of oncology and immunology journals, and that the journal was then published online by BioMed Central, part of Springer Nature.

How to use the number responsibly

It describes the journal, not the article. Citations within a journal are highly skewed, so a single paper’s influence cannot be inferred from the journal’s average.
Compare only within a field. Citation habits differ across disciplines, which is why the JITC announcement itself uses percentile position among immunology and oncology journals rather than the raw value alone.
Quote the data year and source. A bare “JITC has an impact factor of 11.7” is ambiguous; write “11.7 (2025 JCR)”.
Do not use it to assess individuals. The San Francisco Declaration on Research Assessment (DORA) recommends against using journal-based metrics as a surrogate for the quality of individual research articles in hiring, promotion or funding decisions.
Other metrics measure differently. CiteScore comes from Scopus and uses a different window; the two numbers are not interchangeable. For a comparable worked entry on another title, see Frontiers in Immunology impact factor.

Frequently asked questions

What is the impact factor of the Journal for ImmunoTherapy of Cancer?

The journal announced 11.7 for the 2025 Journal Citation Reports, released in June 2026. Check Clarivate’s JCR for the current value.

When was JITC’s first impact factor?

SITC announced it on 26 June 2018: 8.374, based on 2017 citations to items published in 2015 and 2016.

Who publishes JITC?

JITC is the journal of SITC. At its first impact factor in 2018 it was published online by BioMed Central, part of Springer Nature.

Sources

OncoDaily, republished JITC post, “JITC’s 2025 Impact Factor increased to 11.7”, 19 June 2026: oncodaily.com/voices/jitc523758 (read 7 November 2026).
SITC, “Journal for ImmunoTherapy of Cancer receives first impact factor”, 26 June 2018: sitcancer.org (read 7 November 2026).

Use in your systems

JATS XML <role> element

xml

<role vocab="credit"
      vocab-identifier="https://casrai.org/dictionary/"
      vocab-term="Journal for ImmunoTherapy of Cancer (JITC) Impact Factor"
      vocab-term-identifier="https://casrai.org/dictionary/term/journal-for-immunotherapy-of-cancer-impact-factor" />

Schema.org DefinedTerm (JSON-LD)

json

{
  "@context": "https://schema.org",
  "@type": "DefinedTerm",
  "@id": "https://casrai.org/dictionary/term/journal-for-immunotherapy-of-cancer-impact-factor",
  "name": "Journal for ImmunoTherapy of Cancer (JITC) Impact Factor",
  "identifier": "https://casrai.org/dictionary/term/journal-for-immunotherapy-of-cancer-impact-factor",
  "description": "The Journal Impact Factor assigned by Clarivate's Journal Citation Reports to the Journal for ImmunoTherapy of Cancer (JITC): the citations received in a data year by JITC items published in the two preceding years, divided by the number of citable items from those years. JITC announced 11.7 for the 2025 data year.",
  "inDefinedTermSet": "https://casrai.org/dictionary/domain/publishing#set",
  "url": "https://casrai.org/dictionary/term/journal-for-immunotherapy-of-cancer-impact-factor",
  "license": "https://creativecommons.org/licenses/by/4.0/",
  "publisher": {
    "@id": "https://casrai.org/#organization"
  },
  "author": {
    "@id": "https://casrai.org/#editorial-team"
  },
  "datePublished": "2026-11-08T02:45:22",
  "dateModified": "2026-11-08T02:45:22",
  "inLanguage": "en-GB",
  "isAccessibleForFree": true
}